RESUMEN
Biomaterials have been shown to significantly improve the outcome of cellular reparative approaches for Parkinson's disease in experimental studies because of their ability to provide transplanted cells with a supportive microenvironment and shielding from the host immune system. However, given that the margin for improvement in such reparative therapies is considerable, further studies are required to fully investigate and harness the potential of biomaterials in this context. Given that several recent studies have demonstrated improved brain repair in Parkinsonian models when using dopaminergic grafts derived from younger foetal donors, we hypothesized that encapsulating these cells in a supportive biomaterial would further improve their reparative efficacy. Thus, this study aimed to determine the impact of a GDNF-loaded collagen hydrogel on the survival, reinnervation, and functional efficacy of dopaminergic neurons derived from young donors. To do so, hemi-Parkinsonian (6-hydroxydopamine-lesioned) rats received intrastriatal transplants of embryonic day 12 cells extracted from the rat ventral mesencephalon either alone, in a collagen hydrogel, with GDNF, or in a GDNF-loaded collagen hydrogel. Methamphetamine-induced rotational behaviour was assessed at three weekly intervals for a total of 12 weeks, after which rats were sacrificed for postmortem assessment of graft survival. We found that, following intrastriatal transplantation to the lesioned striatum, the GDNF-loaded collagen hydrogel significantly increased the survival (4-fold), reinnervation (5.4-fold), and functional efficacy of the embryonic day 12 dopaminergic neurons. In conclusion, this study further demonstrates the significant potential of biomaterial hydrogel scaffolds for cellular brain repair approaches in neurodegenerative diseases such as Parkinson's disease.
Asunto(s)
Materiales Biocompatibles/uso terapéutico , Colágeno/uso terapéutico , Neuronas Dopaminérgicas/trasplante , Trasplante de Tejido Fetal/métodos , Factor Neurotrófico Derivado de la Línea Celular Glial/uso terapéutico , Supervivencia de Injerto , Hidrogeles/uso terapéutico , Mesencéfalo/trasplante , Neostriado/cirugía , Enfermedad de Parkinson/cirugía , Animales , Conducta Animal/fisiología , Modelos Animales de Enfermedad , Embrión de Mamíferos , Masculino , Oxidopamina , Ratas , Ratas Sprague-DawleyRESUMEN
Stem cell grafts have been advocated as experimental treatments for neurological diseases by virtue of their ability to offer trophic support for injured neurons and, theoretically, to replace dead neurons. Human embryonic stem cells (HESCs) are a rich source of neural precursors (NPs) for grafting, but have been questioned for their tendency to form tumors. Here we studied the ability of HESC-derived NP grafts optimized for cell number and differentiation stage prior to transplantation, to survive and stably differentiate and integrate in the basal forebrain (neostriatum) of young adult nude rats over long periods of time (6 months). NPs were derived from adherent monolayer cultures of HESCs exposed to noggin. After transplantation, NPs showed a drastic reduction in mitotic activity and an avid differentiation into neurons that projected via major white matter tracts to a variety of forebrain targets. A third of NP-derived neurons expressed the basal forebrain-neostriatal marker dopamine-regulated and cyclic AMP-regulated phosphoprotein. Graft-derived neurons formed mature synapses with host postsynaptic structures, including dendrite shafts and spines. NPs inoculated in white matter tracts showed a tendency toward glial (primarily astrocytic) differentiation, whereas NPs inoculated in the ventricular epithelium persisted as nestin(+) precursors. Our findings demonstrate the long-term ability of noggin-derived human NPs to structurally integrate tumor-free into the mature mammalian forebrain, while maintaining some cell fate plasticity that is strongly influenced by particular central nervous system (CNS) niches.
Asunto(s)
Células Madre Embrionarias/fisiología , Células Madre Embrionarias/trasplante , Neostriado/fisiología , Trasplante de Células Madre/métodos , Células Madre/fisiología , Trasplante Heterólogo/fisiología , Animales , Proteínas Portadoras/metabolismo , Proteínas Portadoras/farmacología , Diferenciación Celular/fisiología , Línea Celular Tumoral , Supervivencia Celular/fisiología , Células Madre Embrionarias/citología , Supervivencia de Injerto/fisiología , Conos de Crecimiento/fisiología , Conos de Crecimiento/ultraestructura , Humanos , Masculino , Ratones , Ratones Endogámicos ICR , Neostriado/citología , Neostriado/cirugía , Vías Nerviosas/citología , Vías Nerviosas/fisiología , Neuroglía/citología , Neuroglía/metabolismo , Neuronas/citología , Neuronas/metabolismo , Fosfoproteínas/metabolismo , Ratas , Ratas Desnudas , Células Madre/citología , Sinapsis/ultraestructuraRESUMEN
AIMS: This study was aimed to elucidate if bone marrow stromal cells (BMSC) could ameliorate cognitive dysfunction due to chronic cerebral ischemia when transplanted into the brain. METHODS: The BMSC were harvested from green fluorescence protein (GFP)-expressing mice. Wistar rats were subjected to bilateral common carotid artery (CCA) ligation. The BMSC (4 × 105 cells) or vehicle were stereotactically injected into the right striatum 24 h after the insult. Cognitive function was evaluated with the Morris water maze task after 3 and 5 weeks. Histological analysis was performed after 6 weeks. RESULTS: Cognitive function was significantly impaired in the vehicle-transplanted animals, when compared with the non-CCA-ligation animals. BMSC transplantation significantly improved it. The BMSC were widely distributed in the ischemic brain, including the neocortex, white matter and hippocampus, and some of them expressed the phenotypes of neurons, astrocytes and endothelium. They also significantly ameliorated white matter damage. CONCLUSIONS: These findings strongly suggest that the BMSC may have the potential to attenuate white matter injury and improve cognitive dysfunction due to chronic cerebral ischemia. The present results would shed light on the potential of a novel strategy, cell therapy against ischemia-related cognitive dysfunction.
Asunto(s)
Células de la Médula Ósea/citología , Lesiones Encefálicas/prevención & control , Isquemia Encefálica/patología , Encéfalo/fisiología , Trastornos del Conocimiento/prevención & control , Regeneración Nerviosa/fisiología , Análisis de Varianza , Animales , Trasplante de Médula Ósea , Encéfalo/irrigación sanguínea , Encéfalo/citología , Encéfalo/cirugía , Lesiones Encefálicas/etiología , Lesiones Encefálicas/patología , Lesiones Encefálicas/cirugía , Isquemia Encefálica/complicaciones , Arteria Carótida Común , Diferenciación Celular/fisiología , Movimiento Celular/fisiología , Trastornos del Conocimiento/etiología , Trastornos del Conocimiento/patología , Trastornos del Conocimiento/cirugía , Modelos Animales de Enfermedad , Proteínas Fluorescentes Verdes/metabolismo , Sustancias Luminiscentes/metabolismo , Masculino , Aprendizaje por Laberinto , Ratones , Ratones Transgénicos , Neostriado/patología , Neostriado/cirugía , Ratas , Ratas Wistar , Estadísticas no Paramétricas , Células del Estroma/citología , Células del Estroma/trasplanteRESUMEN
BACKGROUND: Cell transplantation is expected to be a promising treatment for Parkinson's disease (PD), in which re-innervation of the host striatum by grafted dopamine (DA) neurons is essential. In particular, the dorsolateral part of the striatum is important because it is the target of midbrain A9 DA neurons, which are degenerated in PD pathology. The effect of exercise on the survival and maturation of grafted neurons has been reported in several neurological disease models, but never in PD models. OBJECTIVE: We investigated how exercise influences cell transplantation for PD, especially from the viewpoint of cell survival and neurite extensions. METHODS: Ventral mesencephalic neurons from embryonic (E12.5) rats were transplanted into the striatum of adult 6-OHDA-lesioned rats. The host rats then underwent treadmill training as exercise after the transplantation. Six weeks after the transplantation, they were sacrificed, and the grafts in the striatum were analyzed. RESULTS: The addition of exercise post-transplantation significantly increased the number of surviving DA neurons. Moreover, it promoted neurite extensions from the graft toward the dorsolateral part of the striatum. CONCLUSIONS: This study indicates a beneficial effect of exercise after cell transplantation in PD.
Asunto(s)
Neuronas Dopaminérgicas/trasplante , Terapia por Ejercicio , Supervivencia de Injerto/fisiología , Neostriado/cirugía , Neuritas/fisiología , Enfermedad de Parkinson/rehabilitación , Enfermedad de Parkinson/cirugía , Condicionamiento Físico Animal/fisiología , Animales , Modelos Animales de Enfermedad , Embrión de Mamíferos , Oxidopamina , Ratas , Ratas Sprague-Dawley , Ratas TransgénicasRESUMEN
Background. Autologous neural cell ecosystem (ANCE) transplantation improves motor recovery in MPTP monkeys. These motor symptoms were assessed using semi-quantitative clinical rating scales, widely used in many studies. However, limitations in terms of sensitivity, combined with relatively subjective assessment of their different items, make inter-study comparisons difficult to achieve. Objective. The aim of this study was to quantify the impact of MPTP intoxication in macaque monkeys on manual dexterity and assess whether ANCE can contribute to functional recovery. Methods. Four animals were trained to perform 2 manual dexterity tasks. After reaching a motor performance plateau, the animals were subjected to an MPTP lesion. After the occurrence of a spontaneous functional recovery plateau, all 4 animals were subjected to ANCE transplantation. Results. Two of 4 animals underwent a full spontaneous recovery before the ANCE transplantation, whereas the 2 other animals (symptomatic) presented moderate to severe Parkinson's disease (PD)-like symptoms affecting manual dexterity. The time to grasp small objects using the precision grip increased in these 2 animals. After ANCE transplantation, the 2 symptomatic animals underwent a significant functional recovery, reflected by a decrease in time to execute the different tasks, as compared with the post-lesion phase. Conclusions. Manual dexterity is affected in symptomatic MPTP monkeys. The 2 manual dexterity tasks reported here as pilot are pertinent to quantify PD symptoms and reliably assess a treatment in MPTP monkeys, such as the present ANCE transplantation, to be confirmed in a larger cohort of animals before future clinical applications.
Asunto(s)
Conducta Animal/fisiología , Trasplante de Células , Intoxicación por MPTP/fisiopatología , Intoxicación por MPTP/terapia , Neostriado/fisiopatología , Recuperación de la Función/fisiología , Animales , Modelos Animales de Enfermedad , Femenino , Macaca fascicularis , Destreza Motora , Neostriado/cirugía , Proyectos Piloto , Trasplante AutólogoRESUMEN
OBJECTIVE: The purpose of this study was to investigate the role of deep brain stimulation (DBS) of the globus pallidus internus (GPi) in dopamine and dopamine transporter metabolism and to explore the regulatory role of DBS on dopaminergic neurons in Tourette syndrome by constructing an autoimmune model. METHODS: Serum with high concentrations of antinuclear antibodies or phosphate-buffered saline solution was injected into the striatum of rats by a stereotactic technique and micropump. Then, electrodes were planted in the rats' globus pallidus internus. Concentrations of dopamine and dopamine transporter in the striatum were detected by enzyme-linked immunosorbent assay, immunohistochemistry, and Western blot analysis after 7 days of high-frequency stimulation (130 Hz). RESULTS: The tic behavior score of rats in the Tourette syndrome group was higher than that of rats in the control group (P < 0.01). After high-frequency stimulation, the scores of the Tourette syndrome model group and the control group significantly decreased. The concentration of dopamine in the Tourette syndrome model group and the control group also significantly decreased after electric stimulation (P < 0.05). In addition, immunohistochemical analysis and Western blot test results showed that dopamine transporter in the Tourette syndrome model nonstimulation group was lower than in the Tourette syndrome model stimulation group, and that dopamine transporter in the control nonstimulation group was lower than in the control stimulation group (P < 0.05). CONCLUSIONS: The results of this study show that the mechanism of DBS of the GPi in the treatment of Tourette syndrome involved monoamine neurotransmitters, especially the dopamine system, that affected the metabolism and transport of corresponding neurotransmitters, playing an important role in regulating the concentration of synaptic neurotransmitters and changing the biologic activity of basal ganglia nerve circuits.
Asunto(s)
Estimulación Encefálica Profunda , Estimulación Eléctrica , Globo Pálido/fisiopatología , Síndrome de Tourette/fisiopatología , Síndrome de Tourette/cirugía , Animales , Cuerpo Estriado/fisiopatología , Cuerpo Estriado/cirugía , Estimulación Encefálica Profunda/métodos , Modelos Animales de Enfermedad , Proteínas de Transporte de Dopamina a través de la Membrana Plasmática/metabolismo , Globo Pálido/cirugía , Masculino , Neostriado/fisiopatología , Neostriado/cirugía , Ratas Sprague-Dawley , Resultado del TratamientoRESUMEN
Ventral mesencephalic (VM) precursor cells are of interest in the search for transplantable dopaminergic neurons for cell therapy in Parkinson's disease (PD). In the present study we investigated the survival and functional capacity of in vitro expanded, primary VM precursor cells after intrastriatal grafting to a rat model of PD. Embryonic day 12 rat VM tissue was mechanically dissociated and cultured for 4 or 8 days in vitro (DIV) in the presence of FGF2 (20 ng/ml), FGF8 (20 ng/ml) or without mitogens (control). Cells were thereafter differentiated for 6 DIV by mitogen withdrawal and addition of serum. After differentiation, significantly more tyrosine hydroxylase-immunoreactive (TH-ir), dopamine-producing neurons were found in FGF2- and FGF8-expanded cultures compared to controls. Moreover, expansion for 4 DIV resulted in significantly more TH-ir cells than expansion for 8 DIV both for FGF2 (2.4 fold; P<0.001) and FGF8 (3.8 fold; P<0.001) treated cultures. The functional potential of the expanded cells (4 DIV) was examined after grafting into striatum of aged 6-hydroxydopamine-lesioned rats. Amphetamine-induced rotations performed 3, 6 and 9 weeks postgrafting revealed that grafts of FGF2-expanded cells induced a significantly faster and better functional recovery than grafts of FGF8-expanded cells or control cells (P<0.05 for both). Grafts of FGF2-expanded cells also contained significantly more TH-ir cells than grafts of FGF8-expanded cells (P<0.05) or control cells (P<0.01). In conclusion, FGF2-mediated pregrafting expansion of primary VM precursor cells considerably improves dopaminergic cell survival and functional restoration in a rat model of PD.
Asunto(s)
Factor 2 de Crecimiento de Fibroblastos/farmacología , Factor 8 de Crecimiento de Fibroblastos/farmacología , Mesencéfalo/patología , Neuronas/fisiología , Enfermedad de Parkinson/patología , Células Madre/efectos de los fármacos , Adrenérgicos , Anfetamina/farmacología , Animales , Conducta Animal/efectos de los fármacos , Células Cultivadas , Estimulantes del Sistema Nervioso Central/farmacología , Modelos Animales de Enfermedad , Embrión de Mamíferos , Femenino , Trasplante de Tejido Fetal , Actividad Motora/efectos de los fármacos , Neostriado/metabolismo , Neostriado/cirugía , Oxidopamina/toxicidad , Enfermedad de Parkinson/etiología , Enfermedad de Parkinson/cirugía , Ratas , Ratas Sprague-Dawley , Células Madre/fisiología , Factores de Tiempo , Tirosina 3-Monooxigenasa/metabolismoRESUMEN
Transplantation of bone marrow stromal cells (BMSC) has recently been demonstrated to provide neuroprotection in animal models of brain injuries such as ischemia and trauma. The present study was undertaken to explore whether BMSC can promote the survival of dopamine (DA) neurons in neuronal insult models in vitro. We also examined whether BMSC can increase the survival rate of embryonic DA neurons grafted into the striatum of a rat model of Parkinson's disease (PD). Treatment with conditioned media derived from BMSC cultures was found to significantly prevent the death of DA neurons in in vitro cell injury models such as serum deprivation and exposure to the neurotoxin 6-OHDA. In a transplantation study, we also found that the survival of grafted DA cells was significantly enhanced by treating donor cells with the conditioned media at the steps of both cell dissociation and implantation. The results suggest that BMSC may secrete diffusible factors able to protect DA neurons against neuronal injuries. Indeed, BMSC expressed mRNA encoding brain-derived neurotrophic factor, fibroblast growth factor-2 and glial cell line-derived neurotrophic factor, all of which have previously been shown to exhibit potent neurotrophic effects on DA cells. Enzyme-linked immunosorbent assay revealed that the cells release these growth factors into culture media. The present data indicate that BMSC may be a potential donor source of cell-based regenerative therapy for PD where the progressive loss of the midbrain DA neurons takes place.
Asunto(s)
Células de la Médula Ósea/metabolismo , Trasplante de Tejido Encefálico , Supervivencia Celular/fisiología , Dopamina/metabolismo , Trasplante de Tejido Fetal , Neostriado/cirugía , Neuronas/trasplante , Animales , Factores Biológicos/fisiología , Células de la Médula Ósea/citología , Muerte Celular/fisiología , Células Cultivadas , Técnicas de Cocultivo , Medios de Cultivo Condicionados/metabolismo , Modelos Animales de Enfermedad , Supervivencia de Injerto/fisiología , Masculino , Mesencéfalo/citología , Mesencéfalo/embriología , Mesencéfalo/trasplante , Ratones , Neostriado/citología , Neuronas/citología , Neuronas/metabolismo , Trastornos Parkinsonianos/patología , Trastornos Parkinsonianos/cirugía , Ratas , Ratas Sprague-Dawley , Células del Estroma/citología , Células del Estroma/metabolismoRESUMEN
A segment of tibial nerve was autografted to the right corpus striatum of deeply anesthetized adult rats; the distal graft was left beneath the scalp. Horseradish peroxidase (HRP) conjugates were injected into the distal graft after 2-30 weeks, and the animals were killed 2-3 days later. Small numbers of neostriatal perikarya were HRP labeled at all survival times; most were large (ca. 20 microm in diameter), and many contained acetycholine esterase (AChE). Many more neurons were labelled in the substantia nigra pars compacta (SNpc) 4 weeks or more after grafting. When the graft encroached on the globus pallidus, numerous pallidal neurons, most of them AChE positive, were also labeled. Nigrostriatal neurons, a population of pallidal cholinergic neurons, and a subclass (or classes) of neostriatal neurons, including cholinergic interneurons, thus can be classified as central nervous system (CNS) neurons with a relatively strong regenerative response. In a second experimental series, animals were killed 1-4 weeks after grafting, and sections were probed for the expression of mRNAs encoding growth-associated protein 43 (GAP-43) and the cell adhesion molecules N-CAM and L1. Subpopulations of mostly large neurons scattered throughout the neostriatum gave moderate signals for GAP-43 and N-CAM mRNAs and a stronger signal for L1 mRNAs. Most SNpc neurons were strongly labeled with all three probes. Neostriatal grafts had no apparent effect on the expression of any of the mRNAs in the SNpc or on L1 and N-CAM mRNAs in the striatum. However, GAP-43 mRNA levels were increased in a few, mainly large neostriatal neurons around the graft tip, resembling the HRP-labeled cells. In contrast, previous work has shown upregulation (from an undetectable level) of GAP-43 and L1 mRNAs in neurons regenerating axons into grafts placed in the thalamus and cerebellum. Thus, GAP-43 and L1 mRNA expression, but not necessarily marked upregulation, may correlate with, and be intrinsic determinants of, the ability of CNS neurons to regenerate their axons.
Asunto(s)
Moléculas de Adhesión Celular Neuronal/biosíntesis , Neostriado/cirugía , Regeneración Nerviosa/fisiología , Sustancia Negra/fisiología , Nervio Tibial/trasplante , Acetilcolinesterasa/análisis , Animales , Axones/fisiología , Femenino , Proteína GAP-43/biosíntesis , Peroxidasa de Rábano Silvestre/análisis , Complejo de Antígeno L1 de Leucocito , Glicoproteínas de Membrana/biosíntesis , Neostriado/citología , Moléculas de Adhesión de Célula Nerviosa/biosíntesis , Neuronas/fisiología , Ratas , Ratas Sprague-Dawley , Sustancia Negra/citología , Trasplante Autólogo , Regulación hacia ArribaRESUMEN
Embryonic neurons transplanted to the adult CNS extend axons only for a developmentally defined period. There are certain intercellular factors that control the axonal extension, one of which may be the expression of the bcl-2 protein. In this study, rats with complete striatal dopamine fiber denervation received embryonic day 14 mouse ventral mesencephalon cells overexpressing human bcl-2 or control wild-type ventral mesencephalon cells. All rats were treated with cyclosporine to prevent rejection and the surviving grafts were analyzed for cell survival and outgrowth of dopaminergic fibers. The results demonstrate that bcl-2 overexpression does not enhance neuronal graft survival. However, the bcl-2 overexpressing neurons had a higher number of dopaminergic fibers that grew longer distances. These results show that overexpression of bcl-2 can result in longer distance axonal growth of transplanted fetal dopaminergic neurons and that genetic modification of embryonic donor cells may enhance their ability to reinnervate a neuronal target territory.
Asunto(s)
Trasplante de Tejido Encefálico/métodos , Dopamina/metabolismo , Supervivencia de Injerto/genética , Conos de Crecimiento/trasplante , Neostriado/cirugía , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Sustancia Negra/trasplante , Animales , Células Cultivadas , Desnervación , Femenino , Feto , Conos de Crecimiento/metabolismo , Conos de Crecimiento/ultraestructura , Humanos , Masculino , Ratones , Ratones Transgénicos , Neostriado/patología , Neostriado/fisiopatología , Oxidopamina , Enfermedad de Parkinson/metabolismo , Enfermedad de Parkinson/fisiopatología , Enfermedad de Parkinson/cirugía , Fenotipo , Proteínas Proto-Oncogénicas c-bcl-2/genética , Ratas , Ratas Sprague-Dawley , Sustancia Negra/citología , Sustancia Negra/metabolismoRESUMEN
Intracerebral neural xenografts elicit a host immune response that results in their rapid rejection. This forms a key barrier to the therapeutic use of xenogeneic tissue transplantation for conditions such as Parkinson's disease. The current study sought to provide insight into the cellular components of donor cell suspensions that are important in stimulating the host rejection response and thereby to suggest rational manipulations of xenogeneic donor tissue that might ultimately enhance its clinical utility. The neural stem cell mitogens, epidermal growth factor and fibroblast growth factor-2, have been used to isolate and expand populations of primordial neural precursor cells from the embryonic pig brain. The immune response elicited by these cells on transplantation into the non-immunosuppressed rat has been fully characterised. In the first experiments, expanded neural precursors were grafted into the hemi-parkinsonian, non-immunosuppressed Sprague-Dawley rat and graft status and host response examined 10, 21, 35 and 60 days post-transplantation. While equivalent primary tissue grafts were completely eliminated at 35 days, grafts of expanded neural precursors with healthy neurofilament-positive projections were present at all time-points, and two large grafts remained even at 60 days. Some grafts appeared to elicit minimal host immune responses at the time-points they were examined, although most did appear to be undergoing a rejection process since a co-ordinated response involving host cytotoxic T-lymphocytes, microglia/macrophages, immunoglobulin M and complement could be demonstrated to varying degrees. Subsequent experiments went on to demonstrate further that expanded precursor populations and primary tissue suspensions differed in their immunogenic profile. Firstly, when primary tissue was injected intraperitoneally into immunocompetent rats a vigorous primary humoral response was generated. No such response was detected following injection of expanded neural precursors. Secondly, flow cytometric analysis revealed small but significant levels of class II porcine major histocompatibility complex expression in primary cell suspensions but no such expression in expanded precursor populations.The results of this study therefore demonstrate that the immunogenicity of porcine neural cell suspensions used for intracerebral grafting is reduced when neural stem cell mitogens are used to expand precursor cells. The implications of these findings in the development of novel xenogeneic cellular therapies for neurodegenerative conditions such as Parkinson's disease are discussed.
Asunto(s)
Trasplante de Tejido Encefálico/efectos adversos , Rechazo de Injerto/inmunología , Inmunocompetencia/inmunología , Neostriado/cirugía , Trastornos Parkinsonianos/cirugía , Trasplante de Células Madre , Trasplante Heterólogo/efectos adversos , Animales , Anticuerpos/sangre , Anticuerpos/inmunología , Antígenos Heterófilos/sangre , Antígenos Heterófilos/inmunología , Biomarcadores/sangre , Trasplante de Tejido Encefálico/métodos , División Celular/efectos de los fármacos , División Celular/inmunología , Corteza Cerebral/citología , Corteza Cerebral/inmunología , Corteza Cerebral/trasplante , Femenino , Feto , Citometría de Flujo , Rechazo de Injerto/metabolismo , Rechazo de Injerto/fisiopatología , Supervivencia de Injerto/inmunología , Mitógenos/farmacología , Neostriado/inmunología , Neostriado/fisiopatología , Neuronas/citología , Neuronas/inmunología , Neuronas/trasplante , Trastornos Parkinsonianos/metabolismo , Trastornos Parkinsonianos/fisiopatología , Ratas , Ratas Sprague-Dawley , Células Madre/citología , Células Madre/inmunología , Porcinos , Trasplante Heterólogo/métodosRESUMEN
Transplantation of embryonic dopaminergic neurons is an experimental therapy for Parkinson's disease, but limited tissue availability and suboptimal survival of grafted dopaminergic neurons impede more widespread clinical application. Glial cell line-derived neurotrophic factor (GDNF) and neurotrophin-4/5 (NT-4/5) exert neurotrophic effects on dopaminergic neurons via different receptor systems. In this study, we investigated possible additive or synergistic effects of combined GDNF and NT-4/5 treatment on rat embryonic (embryonic day 14) nigral explant cultures grown for 8 days. Contrary to cultures treated with GDNF alone, cultures exposed to NT-4/5 and GDNF+NT-4/5 were significantly larger than controls (1.6- and 2.0-fold, respectively) and contained significantly more protein (1.6-fold). Treatment with GDNF, NT-4/5 and GDNF+NT-4/5 significantly increased dopamine levels in the culture medium by 1.5-, 2.5- and 4.7-fold, respectively, compared to control levels, and the numbers of surviving tyrosine hydroxylase-immunoreactive neurons increased by 1.7-, 2.1-, and 3.4-fold, respectively. Tyrosine hydroxylase enzyme activity was moderately increased in all treatment groups compared to controls. Counts of nigral neurons containing the calcium-binding protein, calbindin-D28k, revealed a marked increase in these cells by combined GDNF and NT-4/5 treatment. Western blots for neuron-specific enolase suggested an enhanced neuronal content in cultures after combination treatment, whereas the expression of glial markers was unaffected. The release of lactate dehydrogenase into the culture medium was significantly reduced for GDNF+NT-4/5-treated cultures only. These results indicate that combined treatment with GDNF and NT4/5 may be beneficial for embryonic nigral donor tissue either prior to, or in conjunction with, intrastriatal transplantation in Parkinson's disease.
Asunto(s)
Trasplante de Tejido Encefálico/métodos , Supervivencia de Injerto/fisiología , Neostriado/cirugía , Factores de Crecimiento Nervioso/farmacología , Proteínas del Tejido Nervioso/farmacología , Neuronas/efectos de los fármacos , Enfermedad de Parkinson/cirugía , Sustancia Negra/efectos de los fármacos , Animales , Calbindina 1 , Calbindinas , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/fisiología , Células Cultivadas , Dopamina/metabolismo , Interacciones Farmacológicas/fisiología , Femenino , Feto , Factor Neurotrófico Derivado de la Línea Celular Glial , Supervivencia de Injerto/efectos de los fármacos , Inmunohistoquímica , L-Lactato Deshidrogenasa/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Neuroglía/efectos de los fármacos , Neuroglía/metabolismo , Neuronas/citología , Neuronas/trasplante , Fosfopiruvato Hidratasa/metabolismo , Embarazo , Ratas , Ratas Sprague-Dawley , Proteína G de Unión al Calcio S100/metabolismo , Trasplante de Células Madre , Células Madre/citología , Células Madre/efectos de los fármacos , Sustancia Negra/citología , Sustancia Negra/trasplante , Tirosina 3-Monooxigenasa/metabolismoRESUMEN
The caudate nucleus and putamen form part of a complex but topographically connected circuitry that links the cortex, the basal ganglia and the thalamus. Within this complex system lie a series of functionally and anatomically segregated loops that allow the concurrent processing of a wide range of cognitive and motor information (Alexander et al., 1986; Alexander and Crutcher, 1990). As a constituent of these loops it has been shown that the striatum is involved in movement initiation, response selection and attentional processes (Robbins and Brown, 1990; Alexander, 1994; Lawrence et al., 1998). Although it is the medium spiny GABAergic projection neurones that are primarily lost in HD, it is not sufficient merely to replace the GABA. Instead it is crucial for striatal tissue transplants to integrate with the host tissue in such a way that the cortico-striatal-thalamic circuitry is restored and is functional. Rodent studies have progressed a long way in establishing the principle that striatal grafts can, at least partially, restore function and integrate appropriately with the host (Dunnett and Svendsen, 1993; Björklund et al., 1994; Sanberg et al., 1998) but the limited behavioural repertoire and the undifferentiated striatum meant that it was inevitable that studies should progress into primate models. Anatomical tracing studies have demonstrated that motor, premotor and somatosensory cortical areas send corticostriatal projections primarily to the putamen region in primates, whereas the head and body of the caudate nucleus mostly receive efferent input from associative cortical areas (Kemp and Powell, 1970; Kunzle, 1975, 1977, 1978; Selemon and Goldman-Rakic, 1985). Based on such anatomical, and functional, studies Alexander and colleagues have proposed the existence of at least five cortico-striatal-thalamic loops including a motor, a dorsolateral-prefrontal and an orbito-frontal loop (Alexander et al., 1986). The concentration of motor inputs to the putamen region suggests a particular involvement of this structure in the motor loop. Indeed, unilateral lesions of the putamen disrupt motor performance in the marmoset and generate apomorphine-induced dyskinesias in larger primates (Burns et al., 1995; Kendall et al., 2000). The implantation of striatal grafts into marmosets that had previously received unilateral putamen lesions ameliorated some of the motor impairments, which suggested at least partial restoration of the motor loop. In support of this we found direct evidence of host-graft cortico-striatal connectivity using an anterograde tracer injected in the primary motor cortical region (Kendall et al., 1998a). In larger primates, with lesions of the caudate and putamen, striatal [figure: see text] allografts and xenografts have been shown to reduce apomorphine-induced dyskinesias (Isacson et al., 1989; Hantraye et al., 1992; Palfi et al., 1998). The mechanism by which dyskinesias are elicited is not fully understood but alterations in firing patterns within both segments of the globus pallidus have been identified during dyskinetic movements (Matsumura et al., 1995). It seems likely that it would actually require re-establishment of afferent connections between the implanted putamen and the globus pallidus as well as of functioning dopamine receptors within the graft for the reduction in the dyskinetic profile to be observed. Certainly there is evidence, from rodent studies and the marmoset study described here, that close proximity of the graft to the globus pallidus yields better functional recovery (Isacson et al., 1986). In addition, anatomical tracing studies in rats have demonstrated connections between the implanted tissue and the host globus pallidus (Wictorin et al., 1989b, 1990) However, the relationship between graft placement and functional recovery remains to be fully substantiated.
Asunto(s)
Trasplante de Tejido Encefálico/tendencias , Modelos Animales de Enfermedad , Enfermedad de Huntington/cirugía , Neostriado/trasplante , Primates/cirugía , Animales , Lesiones Encefálicas/inducido químicamente , Trasplante de Tejido Encefálico/métodos , Callithrix/anatomía & histología , Callithrix/fisiología , Callithrix/cirugía , Desnervación/efectos adversos , Desnervación/métodos , Evaluación de la Discapacidad , Supervivencia de Injerto/fisiología , Humanos , Enfermedad de Huntington/patología , Enfermedad de Huntington/fisiopatología , Macaca/anatomía & histología , Macaca/fisiología , Macaca/cirugía , Neostriado/patología , Neostriado/fisiopatología , Neostriado/cirugía , Neurotoxinas/efectos adversos , Primates/anatomía & histología , Primates/fisiología , Putamen/efectos de los fármacos , Putamen/fisiopatología , Putamen/cirugía , Recuperación de la Función/fisiología , Resultado del TratamientoRESUMEN
Stroke remains a major brain disorder that often renders patients severely impaired and permanently disabled. There is no available treatment for reversing these deficits. Hippocampal, striatal and cortical grafting studies demonstrate that fetal cells/tissues, immortalized cells, and engineered cell lines can survive grafting into the ischemic adult brain, correct neurotransmitter release, establish both afferent and efferent connections with the host brain, and restore functional and cognitive deficits in specific models of stroke. The success of neural transplantation depends on several factors: the stroke model (location, extent, and degree of infarction), the donor cell viability and survival at pre- and post-transplantation, and the surgical technique, among others. Further exploitation of knowledge of neural transplantation therapy already available from our experience in treating Parkinson's disease needs to be critically considered for stroke therapy. While the consensus is to create a functional neuronal circuitry in the damaged host brain, there is growing evidence that trophic action of the grafts and host, as well as exogenous application of trophic factors may facilitate functional recovery in stroke. Current treatment modules, specifically that of rehabilitative medicine, should also be explored with neural transplantation therapy. However, validation of neural transplantation and any other treatment for stroke should be critically assessed in laboratory experiments and limited clinical trials. No direct treatment is recognized as safe and effective for reversing the stroke-induced brain damage and functional/cognitive deficits. The first clinical trial of neural transplantation in stroke patients is a mile-stone in stroke therapy, but subsequent large-scale trials should be approached with caution.
Asunto(s)
Isquemia Encefálica/cirugía , Trasplante de Tejido Encefálico/tendencias , Recuperación de la Función/fisiología , Animales , Isquemia Encefálica/patología , Isquemia Encefálica/fisiopatología , Trasplante de Tejido Encefálico/métodos , Línea Celular Transformada/trasplante , Corteza Cerebral/patología , Corteza Cerebral/fisiopatología , Corteza Cerebral/cirugía , Corteza Cerebral/trasplante , Modelos Animales de Enfermedad , Supervivencia de Injerto/fisiología , Hipocampo/patología , Hipocampo/fisiopatología , Hipocampo/cirugía , Hipocampo/trasplante , Humanos , Neostriado/patología , Neostriado/fisiopatología , Neostriado/cirugía , Neostriado/trasplante , Trasplante de Células Madre , Accidente Cerebrovascular/patología , Accidente Cerebrovascular/fisiopatología , Accidente Cerebrovascular/cirugíaRESUMEN
We investigated here the effect of the novel glial cell line-derived neurotrophic factor (GDNF)-family member neurturin (NTN) on transplanted fetal dopamine (DA) neurons. Three groups of rats with complete unilateral 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal DA system received intrastriatal grafts of embryonic ventral mesencephalic tissue. Following transplantation animals received repeated injections of vehicle or NTN (0.3 microg or 3.0 microg) over three weeks posttransplantation. NTN-treated animals had significantly (1.8-fold) more tyrosine hydroxylase-immunoreactive (TH-IR) neurons. Graft volume, TH-IR cell volume and overall dopaminergic host reinnervation remained unchanged. Amphetamine-induced rotation was rapidly compensated in all grafted rats. We conclude that administration of NTN may be a powerful way to increase survival of transplanted fetal DA neurons.
Asunto(s)
Dopamina/metabolismo , Supervivencia de Injerto/efectos de los fármacos , Neostriado/cirugía , Factores de Crecimiento Nervioso/farmacología , Neuronas/trasplante , Anfetamina/farmacología , Animales , Inhibidores de Captación de Dopamina/farmacología , Femenino , Inmunohistoquímica , Mesencéfalo/citología , Mesencéfalo/embriología , Neostriado/enzimología , Fibras Nerviosas/fisiología , Neuronas/metabolismo , Neurturina , Ratas , Ratas Sprague-Dawley , Conducta Estereotipada/efectos de los fármacos , Tirosina 3-Monooxigenasa/metabolismoRESUMEN
Intracerebral grafting combined with gene transfer may provide a powerful technique for local delivery of therapeutic agents into the CNS. The present study was undertaken to: (i) develop a reliable and reproducible automated cell implantation system, (ii) determine optimal implantation parameters of cells into the striatum, (iii) determine upper safe limits of cellular implantation into the neostriatum of monkeys. Autologous fibroblasts were infused into six sites of the striatum in nonhuman primates (Macaca mulatta, n = 11). Twenty-six-gauge cannulae were inserted vertically through cortical entry sites into the striatum (two sites in the caudate nucleus and four sites in the putamen) at predefined coordinates based on magnetic resonance imaging (MRI). The cannulae were guided by an electronically operated, hydraulic micropositioner and withdrawn at controlled rates, while cells (5, 10, 20, 40, or 80 microl/site) were infused simultaneously. Varying infusion rates and cell concentrations were also evaluated. Visualization and evaluation of graft placement were performed using contrast MRI at 3-5 days postsurgery. Animals were monitored for signs of clinical complications and sacrificed 2 weeks following surgery. Postimplantation MRI revealed a tissue mass effect of the implant with shifting of midline, edema, and infiltration of the white tracts at 40 and 80 microl/site. In addition, these animals developed transient hemiparesis contralateral to the implant site. MRI of animals grafted with 20 microl/site exhibited columnar-shaped implants and evidence of infiltration into white matter tracts possibly due to a volume effect. No clinical side effects were seen in this group. At 14 days postsurgery, MRI scans showed consistent columnar grafts (measuring approximately 5 mm in height) throughout the striatum in animals implanted with 5 or 10 microl/site. No signs of clinical side effects were associated with these volumes and postmortem histological examination confirmed MRI observations. Optimal surgical parameters for delivery of cells into the striatum consist of a graft volume of 10 microl/site, an infusion rate of 1.6 microl/min, a cell concentration of 2.0 x 10(5) cells/microl, and a cannula withdrawal rate of 0.75 mm/min. These results show that infusion of cells into the striatum can be done in a safe and routine manner.
Asunto(s)
Encéfalo/cirugía , Trasplante de Células/métodos , Animales , Automatización , Encéfalo/anatomía & histología , Cateterismo/métodos , Trasplante de Células/efectos adversos , Fibroblastos/trasplante , Bombas de Infusión Implantables , Macaca mulatta , Imagen por Resonancia Magnética , Neostriado/cirugíaRESUMEN
Rats were given unilateral 6-hydroxydopamine (6-OHDA) lesions and subsequently received transplants of fetal ventral mesencephalic tissue into the denervated striatum. Four weeks later transplanted animals were tested for graft-mediated reduction of amphetamine-induced rotational behavior. Subsequently, transplanted animals received an intrastriatal injection of either GDNF (10 microg) or citrate buffer into a site lateral to the transplant, and then 6 h later received an injection of either 4.0 microg of 6-OHDA, 8.0 microg of 6-OHDA, or vehicle using the same stereotaxic coordinates that were used for the GDNF/citrate buffer injection. Animals were re-tested for amphetamine-induced rotational behavior 2 weeks later. Histological analysis revealed a significant reduction in the number of cell bodies immunostained for tyrosine hydroxylase (TH+) within the transplant for those animals pretreated with an intrastriatal injection of citrate buffer and subsequently given either dose of 6-OHDA. Transplanted animals pretreated with GDNF and subsequently administered 8.0 microg of 6-OHDA showed a significant reduction of TH+ neurons within the transplant compared to controls, however TH+ cell counts for this group remained significantly higher than the TH+ cell counts for the group of animals receiving the same dose of 6-OHDA but pretreated with citrate buffer. GDNF pretreatment completely protected TH+ cell bodies against 4.0 microg of 6-OHDA. Rotational scores indicated that GDNF provided only partial protection against 6-OHDA neurotoxicity in terms of transplant function. For both groups of transplanted animals receiving GDNF pretreatment and 6-OHDA injections, amphetamine-induced rotational scores dropped below the scores for animals pretreated with citrate buffer but remained significantly higher than the scores for transplanted animals that were not injected with 6-OHDA. Both histological and behavioral measures indicate GDNF partially protects integrated transplants against neurotoxic insult.
Asunto(s)
Trasplante de Tejido Encefálico , Trasplante de Tejido Fetal , Factores de Crecimiento Nervioso , Proteínas del Tejido Nervioso/farmacología , Neuronas/trasplante , Fármacos Neuroprotectores/farmacología , Animales , Supervivencia Celular/efectos de los fármacos , Dopamina/fisiología , Factor Neurotrófico Derivado de la Línea Celular Glial , Masculino , Neostriado/cirugía , Neuronas/química , Neuronas/citología , Neurotoxinas/toxicidad , Oxidopamina/toxicidad , Ratas , Ratas Sprague-Dawley , Simpaticolíticos/toxicidadRESUMEN
Recently, we have shown that rapid eye movement sleep deprivation (REM-SD) in animals with lesions of the nigro-striatal pathway facilitates turning behavior and such increase still occurred even in the presence of dopaminergic grafts. The objective of this work was to determine which DA receptors are preferentially involved. The results showed that the D2 receptor antagonist sulpiride decreases significantly turning behavior of lesioned animals, with no effect whatsoever of the D1 antagonist SCH 23390. When lesioned animals were REM sleep deprived, the D1 but not the D2 receptor antagonist prevented the increase of turning induced by REM-SD. This work suggests that the increase of post-synaptic supersensitivity induced by REM-SD in nigro-striatal lesioned animals is mediated by D1 receptors.
Asunto(s)
Neostriado/fisiología , Receptores de Dopamina D1/fisiología , Privación de Sueño/fisiología , Sueño REM/fisiología , Sustancia Negra/fisiología , Animales , Benzazepinas/farmacología , Antagonistas de Dopamina/farmacología , Antagonistas de los Receptores de Dopamina D2 , Locomoción/efectos de los fármacos , Masculino , Neuronas Motoras/fisiología , Neostriado/citología , Neostriado/cirugía , Ratas , Ratas Wistar , Receptores de Dopamina D1/antagonistas & inhibidores , Receptores de Dopamina D2/fisiología , Rotación , Sustancia Negra/citología , Sustancia Negra/cirugía , Sulpirida/farmacologíaRESUMEN
Bilateral astroglial transplantation into the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys resulted in significant performance improvement in a spatial delayed response task, but failed to modify perseveration in an object retrieval detour task, or to improve motor clinical rating. Results suggest that brain circuits subserving various motor and cognitive performances can be functionally dissociated, and that remaining resources for the reorganization of neural circuits involved in spatial working memory performance in parkinsonian monkeys, appear to be responsive to striatal transplantation of subcultured, fetal striatal astroglial cells.
Asunto(s)
Astrocitos/trasplante , Trasplante de Tejido Encefálico/métodos , Cebus/cirugía , Neostriado/cirugía , Regeneración Nerviosa/fisiología , Trastornos Parkinsonianos/cirugía , Recuperación de la Función/fisiología , Animales , Astrocitos/citología , Astrocitos/metabolismo , Conducta Animal/fisiología , Cebus/anatomía & histología , Cebus/fisiología , Evaluación de la Discapacidad , Proteína Ácida Fibrilar de la Glía/metabolismo , Inmunohistoquímica , Masculino , Memoria a Corto Plazo/fisiología , Neostriado/patología , Neostriado/fisiopatología , Vías Nerviosas/patología , Vías Nerviosas/fisiopatología , Pruebas Neuropsicológicas , Trastornos Parkinsonianos/patología , Trastornos Parkinsonianos/fisiopatología , Desempeño Psicomotor/fisiología , Percepción Espacial/fisiología , Vimentina/metabolismoRESUMEN
The substantia nigra of gestation day 14 was transplanted into the striatum of 3-4-month-old rats to investigate the transplants ultrastructurally at the end of 2 years, as a follow-up to our previous studies. Transplants were of small size in all 10 specimens taken for this study. The changes observed in the transplant and in the interface region with the host striatum were: thickening of the blood vessel walls, perivascular cuffing with lymphocytes and macrophages loaded with tissue debris, degenerating neurons and hypertrophied astroglia containing dense granules indicating ageing or reaction to degeneration and glial processes. The number of surviving neurons in the transplants was small. These were smaller in size and had very few intracytoplasmic membraneous organelles. A higher content of intracytoplasmic ageing lipofuscin pigment was present than in host neurons and age-matched nigral neurons. Synapses were few, and their number varied among transplants. Generally, the synapses were at the interface with the host tissue. The changes observed in all the 2-year-old transplants suggest premature ageing or a slow rejection process. Slow rejection is a possibility, because these rats are only stock-bred, not inbred, and hence they are not completely immunologically compatible.